We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Varian Expands Presence in China

By HospiMedica staff writers
Posted on 09 Jun 2006
Varian Medical Systems (Palo Alto, CA, USA) is breaking ground in May 2006 in Beijing, China, for a new facility that will manufacture medical linear accelerators for treating cancer with radiotherapy. More...


The company has established a wholly foreign-owned enterprise (WFOE), which will own and operate the facility where it will manufacture medical linear accelerators that are exclusively designed for the Chinese market and for global export. This new facility adds capacity complementary to Varian's main manufacturing site in Palo Alto and positions the company to meet increasing global demand for its medical linear accelerators.

Construction on the estimated U.S.$12 million facility will be completed in March 2007, and the company expects to begin its first product shipments from the facility in July 2007. The company has also appointed Wang Xiao Yun, former CEO of BMEI, a Chinese manufacturer of linear accelerators, managing director of Varian Medical Systems Beijing Co., Ltd.

"This important project expands Varian's global manufacturing and service capability in the radiation therapy market with the greatest growth potential in the world,” said Tim Guertin, president and CEO of Varian Medical Systems. "We are especially pleased to have Mr. Wang, China's most experienced radiation therapy executive, to lead this important new enterprise.”

The new state-of-the-art 134,000 square foot plant will employ about 100 people and be located in the Beijing Economic-Technological Development Area (BDA), a well-established industrial zone on the southern edge of Beijing. The expansion builds on Varian's existing sales and service operations in China where it has an installed base of more than 250 linear accelerators in leading academic centers, hospitals, and local cancer clinics throughout the country. Varian has operated in China for more than 25 years.

"This is an important new project that will lead to better cancer care in China with leading technology from Varian Medical Systems,” said Mr. Wang. "Varian has earned a reputation for producing the highest quality, most reliable, and most cost-effective cancer treatment machines in the world. This new enterprise brings this life-saving technology closer to Chinese clinicians and their patients.”



Related Links:
Varian Medical Systems

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.